Organ preservation and transport company Paragonix Technologies has agreed to be acquired through a $477 million deal offered by Getinge—which expects the international transplant market to continue ...

In its second acquisition of 2023—and its largest in several years—Swedish devicemaker Getinge has set its sights on High Purity New England, which churns out a range of products used throughout the ...

Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector ...

GOTHENBURG, Sweden, March 27, 2025 /PRNewswire/ -- Today, Getinge publishes its Annual Report, including Sustainability Report, for 2024. The report summarizes a year characterized by strong growth, ...

Price hikes and cost saving measures aid Getinge's earnings growth Absorbs chunk of near-term tariff costs before pricing measures fully bite US probe into medtech imports doesn't affect Getinge, CEO ...

Q3 adj. EBITA and sales miss analysts' forecasts Orders keep growing organically at 7.4% Deliveries restarted after temporary disruptions in Q3, CEO says Shares fall 6.9% by midday local time Oct 18 ...

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc. The total market for transplants has been growing rapidly in recent years and is ...

Medical technology company Getinge launched its Experience Center in Wayne on Jan. 27 with a virtual event that included demonstrations of its latest advances in technology. Officials including U.S.

Organic Net Sales Growth: 9.5% increase. Order Intake Growth: 4.7% increase organically. Adjusted Gross Profit: SEK4.51 million. Adjusted EBITDA: SEK179 million, margin improved to 13.1%. Tariff Costs ...

After the FDA instructed healthcare facilities to avoid using two Getinge heart devices because of quality and safety concerns, the company stopped promoting the products. In a May 14 news release, ...